SCHEMBL6535013

SCHEMBL6535013

O=C(O)C(O)Cc1ccc(O)c(O)c1.[NaH]

nearest known ligand 0.96

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM6B O15054 1/20 0.96
KDM4E B2RXH2 7/20 0.64
HSD17B10 Q99714 6/20 0.64
TDP1 Q9NUW8 6/20 0.64
ALOX15 P16050 5/20 0.64
RECQL P46063 5/20 0.64
HIF1A Q16665 4/20 0.64
USP2 O75604 3/20 0.64
LCK P06239 3/20 0.64
ADORA3 P0DMS8 2/20 0.64
HTR2A P28223 2/20 0.64
PTGS2 P35354 2/20 0.64
FYN P06241 2/20 0.64
EGFR P00533 1/20 0.64
PTGS1 P23219 1/20 0.64
SLC7A5 Q01650 1/20 0.64
PLA2G1B P04054 1/20 0.60
HPGD P15428 5/20 0.53
MAPT P10636 5/20 0.53
POLB P06746 4/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29085430 1.00 KDM6B (0.96) KDM6BKDM4EHSD17B10TDP1ALOX15
SCHEMBL29085429 1.00 KDM6B (0.96) KDM6BKDM4EHSD17B10TDP1ALOX15
SCHEMBL29350434 0.98 KDM6B (1.00) KDM6BKDM4EHSD17B10TDP1ALOX15
SCHEMBL5691448 0.98 KDM6B (1.00) KDM6BKDM4EHSD17B10TDP1ALOX15
SCHEMBL829784 0.98 KDM6B (1.00) KDM6BKDM4EHSD17B10TDP1ALOX15
SCHEMBL29869020 0.98 KDM6B (1.00) KDM6BKDM4EHSD17B10TDP1ALOX15
SCHEMBL18469325 0.98 KDM6B (1.00) KDM6BKDM4EHSD17B10TDP1ALOX15
SCHEMBL19369740 0.83 KDM6B (0.73) KDM6BKDM4EHSD17B10TDP1ALOX15
SCHEMBL19369736 0.83 KDM6B (0.73) KDM6BKDM4EHSD17B10TDP1ALOX15
SCHEMBL490593 0.82 KDM6B (0.72) KDM6BKDM4EHSD17B10TDP1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117045631-A Application of L-salvianic acid A and its ester in preparing medicament for promoting angiogenesis 西北大学 2023-11-14 CN disclosed
CN-116999423-A Application of L-salvianic acid A and its ester in preparing medicine for preventing and treating liver disease 西北大学 2023-11-07 CN disclosed
CN-116850169-A Application of L-salvianic acid A and L-salvianic acid A esters in anti-aging and whitening 西北大学 2023-10-10 CN disclosed
CN-101310715-A Tanshinol for preparing the medicine for preventing and treating depression and sodium salt thereof TINGXI YU (CN) 2008-11-26 CN disclosed
EP-1206255-A4 COMPOUNDS OBTAINED FROM i SALVIA SPECIES /i HAVING ANTIVIRAL ACTIVITY UNIV GEORGETOWN (US) 2004-02-11 EP disclosed
WO-2001000199-A9 COMPOUNDS OBTAINED FROM SALVIA SPECIES HAVING ANTIVIRAL ACTIVITY UNIV GEORGETOWN (US) 2002-06-13 WO disclosed
EP-1206255-A1 COMPOUNDS OBTAINED FROM i SALVIA SPECIES /i HAVING ANTIVIRAL ACTIVITY GEORGETOWN UNIVERSITY (US) 2002-05-22 EP disclosed
EP-1089747-A1 COMPOUNDS OBTAINED FROM SALVIA SPECIES HAVING ANTIVIRAL ACTIVITY GEORGETOWN UNIVERSITY (US) 2001-04-11 EP disclosed
WO-2001000199-A1 COMPOUNDS OBTAINED FROM SALVIA SPECIES HAVING ANTIVIRAL ACTIVITY GEORGETOWN UNIVERSITY (US) 2001-01-04 WO disclosed
WO-1999066942-A9 COMPOUNDS OBTAINED FROM SALVIA SPECIES HAVING ANTIVIRAL ACTIVITY UNIV GEORGETOWN (US) 2000-06-22 WO disclosed
WO-1999066942-A1 COMPOUNDS OBTAINED FROM SALVIA SPECIES HAVING ANTIVIRAL ACTIVITY GEORGETOWN UNIVERSITY (US) 1999-12-29 WO disclosed